7 completed, 2 recruiting, 1 withdrawn. 10 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 7, Recruiting 2, Withdrawn 1 |
| Phase 2 | 7 | Completed 4, Recruiting 2, Withdrawn 1 |
Follow Borrelia Infections: new trials by email Literature Review of Borrelia Infections trials Research Report on Borrelia Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ceftriaxone for Post-Treatment Lyme Disease Ceftriaxone treatment, Placebo - Post-Treatment Lyme Disease Syndrome | Phase 1 / Phase 2 | Withdrawn | Hackensack Meridian Health | 2026-05-14 | 2026-05-18 | |
| Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Lumbrokinase - Long Covid, Post-treatment Lyme Disease Syndrome | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 120 | 2024-10-09 | 2026-03-13 |
| A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age mRNA-1975, mRNA-1982, Placebo - Lyme Disease | Phase 1 / Phase 2 | Completed | ModernaTX, Inc. | 807 | 2023-07-26 | 2026-07-30 |
| Effects of Psilocybin in Post-Treatment Lyme Disease Psilocybin - Post-Treatment Lyme Disease, Chronic Lyme Disease | Phase 1 | Completed | Johns Hopkins University | 20 | 2022-07-01 | 2025-08-20 |
| Human Immune Response to Ixodes Scapularis Tick Bites Xenodiagnosis Ticks, skin biopsy, blood draw - Tick-borne Diseases, Tick Resistance | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2022-02-28 | 2026-09-22 |
| First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People 2217LS, 0.9% Sodium Chloride (NaCl) - Lyme Disease | Phase 1 | Completed | MassBiologics | 44 | 2021-02-11 | 2022-09-16 |
| Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease Disulfiram - Fatigue, Quality of Life | Phase 1 / Phase 2 | Completed | Research Foundation for Mental Hygiene, Inc. | 11 | 2019-07-31 | 2025-01-09 |
| Treating Post-Lyme Disease Syndrome With A Novel Nutraceutical ReaLife+ (RLP), Inert Brown powder - Post-Lyme Disease Syndrome (PLDS) | Phase 1 / Phase 2 | Completed | Optimal Health Research | 30 | 2019-07-01 | 2026-11-16 |
| Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis VLA15 with Alum, VLA15 without Alum - Lyme Borreliosis, Nervous System | Phase 1 | Completed | Pfizer | 179 | 2017-01-31 | 2023-04-05 |
| Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation Application of SHB001 - Lyme Disease | Phase 1 / Phase 2 | Completed | University of Zurich | 32 | 2010-04-01 | 2010-11-19 |
Lyme Disease (7) · Post-Lyme Disease Syndrome (5) · Fatigue (1) · Fatigue Syndrome, Chronic (1) · Lyme Neuroborreliosis (1) · Post-Acute COVID-19 Syndrome (1) · Tick-Borne Diseases (1)
Bacterial Infections (10) · Bacterial Infections and Mycoses (10) · Gram-Negative Bacterial Infections (10) · Infections (10) · Spirochaetales Infections (10) · Vector Borne Diseases (10) · Tick-Borne Diseases (9) · Chronic Disease (5) · Disease Attributes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Post-Infectious Disorders (5) · Lyme Disease (3) · Nervous System Diseases (2)
Blood Specimen Collection (1) · Disulfiram (1) · Psilocybin (1) · Sodium Chloride (1) · aluminum sulfate (1) · lumbrokinase (1)
Hackensack Meridian Health (1) · Icahn School of Medicine at Mount Sinai (1) · Johns Hopkins University (1) · MassBiologics (1) · ModernaTX, Inc. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Optimal Health Research (1) · Pfizer (1) · Research Foundation for Mental Hygiene, Inc. (1) · University of Zurich (1)
United States (9) · Belgium (1) · Switzerland (1)
Adriana R Marques, M.D. (1) · Albert Garcia-Romeu, PhD (1) · Bindu Balani, MD (1) · Brian A Fallon, MD (1) · David Putrino, PhD, PT (1)